Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene (ENSG00000298549) encodes a long non-coding RNA transcribed antisense to the CNR1 locus, which codes for Cannabinoid receptor 1. Long non-coding RNAs of this type can potentially regulate neighboring protein-coding genes through various epigenetic and transcriptional mechanisms, but the specific biological role, expression pattern, and clinical significance of this transcript remain poorly characterized with no evidence for direct involvement in disease or response to therapy. It is not classified as a receptor, enzyme, or any other canonical drug target, and is primarily cataloged as an RNA gene in genomic databases. No evidence suggests misspelling, missing information, or incorrect assignment, though the lack of functional and clinical annotation limits its utility in most translational research and therapeutic contexts.
None established (mechanisms may involve transcriptional interference, RNA-RNA interactions, or chromatin remodeling, but no specific mechanisms documented for this transcript.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to CNR1 (ENSG00000298549).